Jazz Pharmaceuticals Enters Amendment No. 4 To Credit Agreement On Sept 23, 2026

By Reuters News

- Jazz Pharmaceuticals PLC JAZZ.O:

  • JAZZ PHARMACEUTICALS - UNIT ENTERS AMENDMENT NO. 4 TO CREDIT AGREEMENT ON SEPT 23, 2026 - SEC FILING

  • JAZZ PHARMACEUTICALS - UNIT BORROWS $273.31 MILLION IN ADDITIONAL TRANCHE B-3 DOLLAR TERM LOANS - SEC FILING

  • JAZZ PHARMACEUTICALS - TRANCHE B-3 DOLLAR TERM LOANS MATURE ON MAY 5, 2033 - SEC FILING


Further company coverage: JAZZ.O

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk